Exosomes: Molecular messengers shaping muscle physiology and growth.
Afe AE., Guo X., Badshah F., Li K., Zhou R.
Narrative Review, published in Tissue Cell (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Tissue Cell (2026)
- Country
- Scotland
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41916099
- DOI
- 10.1016/j.tice.2026.103499
Abstract (original English)
Exosomes, a subset of extracellular vesicles, are key mediators of intercellular communication and important regulators of skeletal muscle biology. However, the mechanisms by which they influence muscle growth, metabolism, and interactions with adipose tissue remain underexplored, particularly in livestock and regenerative medicine. This review integrates recent advances elucidating the roles of exosomal cargos, such as microRNAs, proteins, and lipids, in regulating myogenesis, regeneration, fiber-type specification, intramuscular fat deposition, and energy metabolism. It also details the mechanisms by which exosomes modulate key signaling pathways, including the PI3K/Akt/mTOR, TGF-β, Notch, and Wnt/β-catenin pathways, as well as the exosome-mediated cross-talk linking muscle and adipose tissues in metabolic and structural regulation. Furthermore, we examine the potential of engineered exosomes as targeted delivery vehicles to modulate muscle composition, enhance meat quality, and promote tissue regeneration. By integrating mechanistic insights with emerging translational advances, this review highlights the prospective applications of exosome biology in both biomedical research and agricultural biotechnology.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.